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Abstract
We leverage the complementing features of randomized clinical trials (RCTs) and real world
evidence (RWE) to estimate the average treatment effect of the target population. First, we
propose a calibration weighting estimator that uses only covariate information from the RWE
study. Because this estimator enforces the covariate balance between the RCT and RWE
study, the generalizability of the trial-based estimator is improved. We further propose a
doubly robust augmented calibration weighting estimator that achieves the semiparametric
efficiency bound derived under the identification assumptions when the nuisance models are
correctly specified. A data-adaptive nonparametric sieve method is provided as an alternative
to the parametric approach. The sieve method guarantees good approximation of the nuisance
models. We establish asymptotic results under mild regularity conditions, and confirm the
finite sample performances of the proposed estimators by simulation experiments. When the
treatment and outcome information is also available from the RWE study, we borrow its
predictive power to improve the estimation of the nuisance functions under the outcome mean
function transportability assumption. We apply our proposed methods to estimate the effect
of adjuvant chemotherapy in early-stage resected non–small-cell lung cancer integrating data
from a RCT and a sample from the National Cancer Database.
∗The authors gratefully acknowledge please remember to list all relevant funding sources in the unblinded version
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1 Introduction
Randomized clinical trials (RCTs) are the gold standard for evaluation of treatment effects. How-
ever, due to restrictive inclusion and exclusion criteria for patient eligibility, the trial sample is
narrowly defined and can be systematically different from the real-world patient population to
which the new treatment is supposed to be given. Therefore, the findings from RCTs often lack
generalizability to the target population of interest. Real world evidence (RWE) studies often
include large samples that are representative of real-world patient populations; however, there
are concerns about whether or not confounding has been addressed adequately in the analyses of
RWE studies. In cancer research, there is an ongoing discussion on the strengths and limitations
of utilizing data from RCT and RWE in comparative effectiveness analyses (Hahn and Schilsky,
2012; Hershman and Wright, 2012; Korn and Freidlin, 2012). The cancer research community has
reached a consensus on the need to incorporate evidence from real word data, but how to effectively
integrate them in pooled analysis of individual patients data from RCTs remains under-developed.
There is considerable interest in bridging the findings from a RCT to the target population. This
problem has been termed as generalizability (Cole and Stuart, 2010; Stuart et al., 2011; Hernan and
VanderWeele, 2011; Tipton, 2013; O’Muircheartaigh and Hedges, 2014; Stuart et al., 2015; Keiding
and Louis, 2016; Dahabreh et al., 2018; Dahabreh and Hernán, 2019; Dahabreh et al., 2019,?),
external validity (Rothwell, 2005) or transportability (Pearl and Bareinboim, 2011; Rudolph and
van der Laan, 2017) in the statistics literature and has connections to the covariate shift problem in
machine learning (Sugiyama and Kawanabe, 2012). Most existing methods rely on direct modeling
of the sampling score, which is the sampling analog of the propensity score (Rosenbaum and
Rubin, 1983). The subsequent sampling score adjustments include inverse probability of sampling
weighting (IPSW; Cole and Stuart, 2010; Buchanan et al., 2018), stratification (Tipton, 2013;
O’Muircheartaigh and Hedges, 2014), and augmented IPSW (Dahabreh et al., 2018). There are
two major drawbacks in the sampling score adjustment approaches. First, these approaches require
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correct model specification of the sampling score. The IPSW estimators are unstable or inconsistent
if the sampling score is too extreme or misspecified. Second, they assume the RWE sample to be
a simple random sample from the target population and implicitly require either the population
size or all the baseline information of the population to be available. For example, Dahabreh et al.
(2018) set the target population to be all trial-eligible individuals and assumed that all population
baseline covariates are known, which is rarely the case in practice.
In this paper, we consider combining a RCT sample and a RWE sample to estimate the average
treatment effect (ATE) of the target population, where the RCT sample is subject to selection bias
and the RWE sample is representative of the target population with a known sampling mechanism.
It is worth noting that we allow the RWE sample to be a general random sample from the target
population. This relaxation is particularly useful when real-world cohort studies are based on
stratified random sampling in order to sample sufficient representations of some subgroups.
To address the selection bias of the RCT sample, we estimate the sampling score weights di-
rectly by calibrating covariate balance between the RCT sample and the design-weighted RWE
sample, in contrast to the dominant approaches that focus on predicting sample selection prob-
abilities. Calibration weighting (CW) is widely used to integrate auxiliary information in survey
sampling (Wu and Sitter, 2001; Chen et al., 2002; Kott, 2006; Chang and Kott, 2008; Kim et al.,
2016), and causal inference, such as in Constrained Empirical Likelihood (Qin and Zhang, 2007),
Entropy Balancing (Hainmueller, 2012), Inverse Probability Tilting (Graham et al., 2012), and Co-
variate Balance Propensity Score (Imai and Ratkovic, 2014; Fan et al., 2016). Chan et al. (2015)
showed that estimating ATE by calibration weighting can achieve global efficiency. We show that
calibration weighting has several advantages in the data integration problem. First, its estimation
does not require the population baseline covariates or the population size to be available, and it
allows the RWE sample to be a general random sample, not necessarily a simple random sample,
from the target population. Second, the weights are estimated directly from an optimization prob-
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lem instead of inverting the estimated sampling probability, which requires careful monitoring to
avoid extreme weights that result in highly variable estimates. Third, similar to Zhao and Perci-
val (2017), we show that the CW estimator are doubly robust in the sense that the estimator is
consistent if the parameterization for either the outcome or the sampling score model is correctly
specified. The double robustness relies critically on the vector of calibration variables; however,
the literature lacks of a principled guidance on how to choose the calibration variables. To address
this issue, we draw an explicit connection between calibration weighting and estimating equations
under parametric models, which enables us to use penalized estimating equation approach for basis
selection.
We also derive the semiparametric efficiency bound for the ATE under identification assump-
tions. We propose an augmented CW (ACW) estimator that is doubly robust and achieves the
semiparametric efficiency bound if both nuisance models are correctly specified. In the presence
of complex confounding, we adopt the method of sieves (Shen, 1997; Chen, 2007), which allows
flexible data-adaptive estimation of the nuisance functions while retaining usual root-n consistency
under mild regularity conditions. The efficiency of the ACW estimator can be further improved
if we have additional treatment and outcome information from the RWE sample and the outcome
mean function transportability assumption.
The rest of the paper is organized as follows. We formalize the causal framework and assump-
tions in Section 2. The CW estimator is introduced in Section 3. We provide the semiparametric
efficiency bound and propose the augmented CW estimator in Section 4. The finite sample perfor-
mances of the proposed estimators are evaluated and compared in simulations studies in Section
5. We apply the proposed methods to estimate the effect of adjuvant chemotherapy by integrating
the RCT data for early-stage resected non–small-cell lung cancer with the real-world data from the
National Cancer Database in Section 6. Section 7 concludes with future directions.
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2 Basic setup
2.1 Notation: causal effect and two data sources
We let X be the p-dimensional vector of covariates; let A be the treatment assignment with
two levels {0, 1}, where 0 and 1 are the labels for control and active treatments, respectively;
and let Y be the outcome of interest, which can be either continuous or binary. We use the
potential outcomes framework (Neyman, 1923; Rubin, 1974) to formulate the causal problem.
Under the Stable Unit Treatment Value Assumption (Rubin, 1980), for each level of treatment a,
we assume that each subject in the target population has a potential outcome Y (a), representing
the outcome had the subject, possibly counterfactual, been given treatment a. The conditional
average treatment effect (CATE) is defined as τ(X) = E{Y (1) − Y (0) | X}. We are interested
in estimating the population ATE τ0 = E{τ(X)}, where the expectation is taken with respect to
the target population. If the outcome is binary, the ATE is referred to as the average causal risk
difference τ0 = P{Y (1) = 1} − P{Y (0) = 1}.
We consider a scenario where we have access to two samples: one sample is from a RCT that
compares the two treatments, and the other sample is from an observational RWE study that can
be used to characterize the target population. The data structure is demonstrated in Figure 1. The
target population of size N consists of all patients with certain diseases to whom the new treatment
is intended to be given. In practice, it is often difficult to identify the entire population, and the
population size, N , is not necessarily known. Let δ = 1 denote RCT participation, and let δ˜ = 1
denote the RWE study participation. The RWE sample is assumed to be a random sample drawn
from the target population with a known sampling mechanism. Let d = 1/P (δ˜ = 1|X) be the
design weight in the RWE sample. For example, in health research, many cohort studies utilized
stratified sampling to over-represent some subgroups. Suppose the population consists of L strata
with sizes {N1, . . . , NL}, and suppose that the RWE study selects a fixed number of subjects nl from
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Target future patient population (Superpopulation)
{Xi, Yi(0), Yi(1)}Ni=1
{
Xi, Yi(0), Yi(1), δi = 1, δ˜i = 0
}n
i=1
{
Xi, Yi(0), Yi(1), δi = 0, δ˜i = 1
}n+m
i=n+1
RCT Sampling: δi ∼ Unknown RWE Sampling: δ˜i ∼ Known design
RCT Treatment: Ai ∼ Randomization RWE Treatment: Ai ∼ Unknown
Observed RCT Sample{
Xi, Ai, Yi, δi = 1, δ˜i = 0
}n
i=1
Observed RWE Sample{
Xi, (Ai, Yi), δi = 0, δ˜i = 1
}n+m
i=n+1
Figure 1: Demonstration of the sampling and treatment assignment regimes for the RCT and RWE
samples within the target population.
the Nl subjects in the lth stratum. Then, the design weight for subject j from the lth stratum
is dj = Nl/nl. We denote data from the RCT of size n to be {(Xi, Ai, Yi, δi = 1) : i = 1, ..., n};
the data from the RWE study of size m to be either
{
(Xj, δ˜j = 1) : j = n+ 1, . . . , n+m
}
if we
only have covariate information, or
{
(Xj, Aj, Yj, δ˜j = 1) : j = n+ 1, . . . , n+m
}
if treatment and
outcome information are also available in the study. We assume that the RCT sample and the
RWE sample are independent. This assumption is reasonable in our motivating example where
the patients for the two data sources were accrued in two separate time periods. See Section 6 for
details. In general, the accrual time periods of two data sources could overlap and there may be
some patients represented in both sources. However, the probability of having the same patients
in both data sources is often small, which can be practically ignored. We discuss proper inferences
if there are significant overlapping of two sources in Section 7.
7
2.2 Identification assumptions
A fundamental problem in causal inference is that we can observe at most one of the potential
outcomes for an individual subject. To identify the ATE from the observed data, we make the
following assumptions throughout the paper.
Assumption 1 (Consistency) The observed outcome is the potential outcome under the actual
received treatment: Y = AY (1) + (1− A)Y (0).
Assumption 2 (Randomization and Transportability) (i) Y (a)⊥A | (X, δ = 1) for a = 0, 1;
and (ii) E{Y (1)− Y (0) | X, δ = 1} = τ(X).
Assumption 2 (i) holds for the RCT by default. Assumption 2 (ii) requires that the CATE
function is transportable from the RCT to the target population, which is plausible if X captures
all the treatment effect modifiers and there is no trial encouragement (Dahabreh and Hernán,
2019). This assumption relaxes the ignorability assumption on trial participation (Stuart et al.,
2011; Buchanan et al., 2018), i.e., {Y (0), Y (1)}⊥δ | X, and the mean exchangeability assumption
over treatment assignment and trial participation (Dahabreh et al., 2018), i.e. E{Y (a)|X, δ =
1, A = a} = E{Y (a)|X, δ = 1} as well as E{Y (a)|X, δ = 1} = E{Y (a)|X} for a = 0, 1.
Moreover, we require adequate overlap of the covariate distribution between the trial sample
and the target population, and also the treatment groups over the trial sample, formalized by the
following assumption. Define the sampling score as piδ(X) = P (δ = 1 | X) .
Assumption 3 (Positivity) There exists a constant c such that with probability 1, piδ(X) ≥ c >
0; and 0 < P (A = 1|X = x, δ = 1) < 1 for all x such that P (X = x|δ = 1) > 0.
8
Under Assumptions 1–3, the ATE satisfies
τ0 = E{τ(X)} = E[E{Y (1)− Y (0) | X, δ = 1}]
= E
[
δ
piδ(X)
{E(Y | X,A = 1, δ = 1)− E(Y | X,A = 0, δ = 1)}
]
= E
[
δ˜d{E(Y | X,A = 1, δ = 1)− E(Y | X,A = 0, δ = 1)}
]
,
and thus is identifiable.
2.3 Existing estimation methods
Because the RCT assigns treatments randomly to the participants, τ(X) is identifiable and can be
estimated by standard estimators solely from the RCT. However, the covariate distribution of the
RCT sample f(X | δ = 1) is different from that of the target population f(X) in general; therefore,
E{τ(X) | δ = 1} is different from τ0, and the ATE estimator using trial data only is biased of τ0
generally.
A widely-used approach is the IPSW estimator that predicts the sampling score piδ(X) and uses
the inverse of the estimated sampling score to account for the shift of the covariate distribution from
the RCT sample to the target population. Specifically, most of the empirical literature assumes
that piδ(X) follows a logistic regression model piδ(X;η) and can be estimated by piδ(X; η̂). The
IPSW estimator of the ATE is
τˆ IPSW =
∑n
i=1 piδ(Xi; η̂)
−1AiYi∑n
i=1 piδ(Xi; η̂)
−1Ai
−
∑n
i=1 piδ(Xi; η̂)
−1(1− Ai)Yi∑n
i=1 piδ(Xi; η̂)
−1(1− Ai) . (1)
The IPSW estimator has several drawbacks as discussed in Section 1. In the next two sections,
we propose approaches to (i) calibrate the covariate distribution of the RCT sample to that of
the design-weighted RWE sample so that the estimated treatment effects can be generalized to
the target population, and (ii) leverage the predictive power of the RWE sample to improve the
precision for the generalized ATE estimator.
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3 Calibration weighting estimator
We propose to use calibration originated in survey sampling to eliminate the selection bias in the
trial-based ATE estimator. The calibration weighting approach is similar to the idea of entropy
balancing weights introduced by Hainmueller (2012). We calibrate subjects in the RCT sample so
that after calibration, the covariate distribution of the RCT sample empirically matches the target
population. Our insight is that for any vector-valued function g(X),
E
{
δ
piδ(X)
g(X)
}
= E
{
δ˜dg(X)
}
= E{g(X)}.
Here, g(X) contains the covariate functions to be calibrated, which could be moment functions of
the original covariate X or any sensible transformations of X.
To this end, we assign a weight qi to each subject i in the RCT sample so that
N∑
i=1
δiqig(Xi) = g˜, (2)
where g˜ =
∑N
i=1 δ˜idig(Xi)/
∑N
i=1 δ˜idi is a design-weighted estimate of E{g(X)} from the RWE
sample. Constraint (2) is referred to as the balancing constraint, and weights Q = {qi : δi = 1} are
the calibration weights. The balancing constraint calibrates the covariate distribution of the RCT
sample to the target population in terms of g(X). The choice of g(X) is important for both bias
and variance considerations, which we will discuss in Section 4.2.
We estimate Q by solving the following optimization problem:
min
Q
n∑
i=1
qi log qi, (3)
subject to qi ≥ 0, for all i;
∑n
i=1 qi = 1, and the balancing constraint (2).
The objective function in (3) is the entropy of the calibration weights; thus, minimizing this
criteria ensures that the empirical distribution of calibration weights are not too far away from
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the uniform, such that it minimizes the variability due to heterogeneous weights. This optimiza-
tion problem can be solved using convex optimization with Lagrange multiplier. By introducing
Lagrange multiplier λ, the objective function becomes
L(λ,Q) =
n∑
i=1
qi log qi − λ>
{
n∑
i=1
qig(Xi)− g˜
}
. (4)
Thus by minimizing (4), the estimated weights are
q̂i = q(Xi; λ̂) =
exp
{
λ̂>g(Xi)
}
∑n
i=1 exp
{
λ̂>g(Xi)
} ,
and λ̂ solves the equation
U(λ) =
n∑
i=1
exp
{
λ>g(Xi)
} {g(Xi)− g˜} = 0, (5)
which is the dual problem to the optimization problem (3).
Let piAi = P (Ai = 1|Xi, δi = 1) be the treatment propensity score for subject i. For RCTs, it is
common that the propensity score is known with piAi = 0.5, for all i = 1, . . . , n.
Based on the calibration weights, we propose the CW estimator
τˆCW =
n∑
i=1
q̂i
{
AiYi
piAi
− (1− Ai)Yi
1− piAi
}
, (6)
To investigate the properties of the proposed CW estimator, we impose the following regularity
conditions on the sampling designs for both the RWE and the RCT samples.
Assumption 4 Let µg0 = E{g(X)}. The design weighted estimator µ̂g = N−1
∑N
i=1 δ˜idig(Xi)
satisfies V (µ̂g) = O(m−1), and {V (µ̂g)}−1/2(µ̂g − µg0)→ N (0, 1) in distribution, as m→∞.
Assumption 5 The sampling score of RCT participation follows a loglinear model, i.e. piδ(X) =
exp{η>0 g(X)} for some η0.
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Note that if the sampling score follows a logistic regression model piδ(X;η) = exp{η>g(X)}/[1+
exp{η>g(X)}] and the fraction n/N of the RCT sample in the target population is small, the
loglinear model in Assumption 5 is close to the logistic regression model. Our simulation studies
demonstrate that the proposed estimators perform well under a logistic regression model.
In addition, in the estimation of calibration weights we only require specifying g(X). Thus,
calibration weighting evades explicitly modeling either the sampling score model or the out-
come mean models. Under Assumption 5, we show that there is a direct correspondence be-
tween calibration weight q(Xi; λ̂) and the estimated sampling score piδ(Xi; η̂), i.e. q(Xi; λ̂) =
{Npiδ(Xi; η̂)}−1 + op(N−1); see the proof of Theorem 1 in the supplementary materials.
The following assumption is on the linearity of the CATE in g(X).
Assumption 6 τ(X) = γ>0 g(X).
Based on the above assumptions, we establish the double robustness property of the CW esti-
mator in the following theorem and relegate all proofs to the supplementary materials.
Theorem 1 (Double robustness of the CW estimators) Under Assumptions 1–4, if either
Assumption 5 or Assumption 6 holds, not necessarily both, τˆCW in (6) is consistent for τ0.
We provide a simple bootstrap procedure to estimate the variance of the CW estimator. The
first step is to draw B bootstrap samples from both the RCT sample and the RWE sample respec-
tively, which results in B pairs of bootstrapped samples. Then for each resampled pair, we can
obtain a replicate of the CW estimator. The variance of the CW estimator is given by the sample
variance of the B bootstrapped estimators.
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4 Semiparametric efficient estimator
4.1 Augmented calibration weighting estimator
Define the trial conditional outcome mean function as µa,δ(X) = E(Y | X,A = a, δ) for a = 0, 1.
The following theorem gives the semiparametric efficiency bound for τ0 in our data integration
setting.
Theorem 2 (Semiparametric efficiency bound) Under Assumptions 1 - 4, the semiparamet-
ric efficiency score for τ0 is
φ(X,A, Y, δ, δ˜) =
δ
piδ(X)
[
A {Y − µ1,δ(X)}
piA
− (1− A) {Y − µ0,δ(X)}
1− piA
]
+ δ˜d {τ(X)− τ0} .
The semiparametric efficiency bound for τ0 is
Veff = E
[
δ
piδ(X)2
{
V {Y (1)|X, δ}
piA
+
V {Y (0)|X, δ}
1− piA
}
+ δ˜d2 {τ(X)− τ0}2
]
.
The semiparametric efficiency bound is decomposed naturally into two components as shown in
its form. The first term accounts for the variance of potential outcomes adjusted for treatment
assignment and sample selection; the second term quantifies the treatment heterogeneity in the
RWE sample. Rudolph and van der Laan (2017) also provided a semiparametric efficiency score
for transporting the ATE from one study site to another, where one site is regarded as a population
without the sampling assumption.
Remark 1 We note that Veff is always smaller than the asymptotic variance of τCW. The proof is
provided in the supplementary materials.
The result in Theorem 2 serves as a foundation to derive efficient estimators combining two
data sources. Under Assumption 2, τ(X) = µ1,δ=1(X) − µ0,δ=1(X). The score φ(X,A, Y, δ, δ˜) has
unknown nuisance functions piδ(X) and µa,δ=1(X), (a = 0, 1). Therefore, to estimate τ0, we posit
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models for the nuisance functions, denoted by piδ(X;η) and µa,δ=1(X;βa). For example, we assume
piδ(X) is a loglinear model as in Assumption 5. By the correspondence between the loglinear model
and the calibration weighing algorithm, we can estimate η0 following the optimization algorithm
in (3). We also posit models µa,δ=1(X;βa), a = 0, 1. By Assumption 2, we are able to obtain a
consistent estimator β̂a based on the trial sample.
Based on the semiparametric efficiency score, we propose a new estimator for the ATE. As the
outcome mean models in the semiparametric efficiency score can be viewed as an augmentation
to the CW estimator, we refer to the proposed estimator as the augmented calibration weighting
(ACW) estimator, and it is given by
τˆACW =
N∑
i=1
δiq̂i
Ai
{
Yi − µ1,δ=1(Xi; β̂1)
}
piAi
−
(1− Ai)
{
Yi − µ0,δ=1(Xi; β̂0)
}
1− piAi

+
{
N∑
i=1
δ˜idi
}−1 N∑
i=1
δ˜idi
{
µ1,δ=1(Xi; β̂1)− µ0,δ=1(Xi; β̂0)
}
. (7)
We show in the following theorem that τˆACW achieves double robustness and local efficiency.
Theorem 3 (Double robustness and local efficiency of the ACW estimator) Under As-
sumptions 1–4, if either Assumption 5 or that µa,δ=1(X;βa) (a = 0, 1) is correctly specified, not
necessarily both, τˆACW is consistent for τ0. When both Assumption 5 and Assumption 6 hold,
N1/2(τˆACW − τ0) → N (0, Veff) in distribution, as n → ∞, where Veff is defined in Theorem 2, i.e.
τˆACW is locally efficient with its asymptotic variance achieves the semiparametric efficiency bound.
For a vector v, we use ‖v‖2 = (v>v)1/2 to denote its Euclidean norm. For a function f(V ),
where V is a generic random variable, we define its L2-norm as ‖f(V )‖ =
{∫
f(v)2dP (v)
}1/2 . By
the empirical processes theory, the effect of nuisance parameter estimation in τˆACW−τ0 is bounded
by ‖piδ(X; η̂) − piδ(X)‖
∑1
a=0‖µa,δ=1(X; β̂a) − µa,δ=1(X)‖; see Section S1.4 in the supplementary
materials for details. If this bound is of rate op(n−1/2), then it is asymptotically negligible, and
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thus τˆACW is semiparametric efficient. This rate can occur in various scenarios. For example,
if all nuisance models are correctly specified parametric models, both ‖piδ(X; η̂) − piδ(X)‖ and∑1
a=0‖µa,δ=1(X; β̂a)−µa,δ=1(X)‖ are Op(n−1/2) and their product is op(n−1/2), then τˆACW is locally
efficient. Another instance is to approximate the nuisance functions by flexible machine learning
methods. In such case, if both ‖piδ(X; η̂) − piδ(X)‖ and
∑1
a=0‖µa,δ=1(X; β̂a) − µa,δ=1(X)‖ reach
op(n
−1/4), then their product still achieves op(n−1/2), and therefore is asymptotically negligible. In
general, there exist different combinations of convergence rates of piδ(X; η̂) and µa,δ=1(X; β̂a) (a =
0, 1) that result in a negligible error bound accommodating different smoothness conditions of the
underlying true nuisance functions. The following theorem formalizes the above statement.
Theorem 4 Let piδ(X; η̂) and µa,δ=1(X; β̂a) (a = 0, 1) be general semiparametric models for piδ(X)
and µa,δ=1(X) (a = 0, 1), respectively. Assume the following regularity conditions hold:
Condition 1 ‖piδ(X; η̂)− piδ(X)‖ = op(1), and ‖µa,δ=1(X; β̂a)− µa,δ=1(X)‖ = op(1), for a = 0, 1;
Condition 2 ‖piδ(X; η̂)− piδ(X)‖
∑1
a=0 ‖µa,δ=1(X; β̂a)− µa,δ=1(X)‖ = op(n−1/2).
Then τˆACW is consistent for τ0 and achieves the semiparametric efficiency bound.
The semiparametric efficiency bound is attained as long as either η̂ or (β̂0, β̂1) approximate the
underlying sampling score model or the outcome models well. Condition 1 states that we require
that the posited models to be consistent. Condition 2 states that the combined rate of convergence
of the posited models is of op(n−1/2). In Section 4.2, we construct such estimators using the method
of sieves, which satisfies Condition 1 and 2 under mild regularity conditions.
For locally efficient estimator τˆACW, the variance estimator can be calculated empirically as
V̂ ACW =
N∑
i=1
[
δiq̂i
piδ(Xi; η̂)
{
V̂ (Yi|Xi, Ai = 1, δi = 1)
piA
+
V̂ (Yi|Xi, Ai = 0, δi = 1)
1− piA
}
+
{
N∑
i=1
δ˜idi
}−1
δ˜id
2
i {τˆ(Xi)− τˆ}2
 . (8)
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For a continuous outcome, V̂ (Y |X,A = a, δ = 1) is an non-parametric estimator
V̂ (Y |X,A = a, δ = 1) =
∑n
j=1 δiI(Aj = a)Kh(X −Xj)
{
Yj − µa,δi=1(Xj; β̂a)
}2∑n
j=1 δiI(Aj = a)Kh(X −Xj)
,
whereKh(x) is a kernel function. For a binary outcome, V̂ (Y |X,A = a) = µ̂a,δ=1(X; β̂a)
{
1− µ̂a,δ=1(X; β̂a)
}
.
The bootstrap variance estimator introduced in Section 3 can be applied here as well. The boot-
strap variance estimator is more straightforward than (8), and it can accommodate situations
where either one of the nuisance models is misspecified. Thus, the bootstrap variance estimator is
recommended in practice and adopted in the simulation study.
4.2 Semiparametric models by the method of sieves
To overcome the model misspecification issue inherent to parametric models, we consider the
method of sieves (Geman and Hwang, 1982), which allows flexible models for piδ(X) and µa,δ=1(X), (a =
0, 1) and also achieves Conditions 1 and 2 under mild regularity conditions. In comparison with
other nonparametric methods such as the kernel method, the sieve method is particularly well-
suited to calibration weighting. Although general sieve basis functions such as Fourier series,
splines, wavelets, and artificial neural networks (see Chen, 2007 for a comprehensive review) are
applicable, the power series is the most common class of functions. For a p-vector of non-negative
integers κ = (κ1, . . . , κp), let |κ| =
∑p
l=1 κl and X
κ =
∏p
l=1 X
κl
l . Define a series {κ(k) : k = 1, 2, . . .}
for all distinct vectors of κ such that |κ(k)| ≤ |κ(k+1)|. Based on this series, we consider aK-vector
g(X) = {g1(X), . . . , gK(X)}> = {Xκ(1), . . . , Xκ(K)}>.
To accommodate different type of variables, we approximate piδ(X) and µa,δ=1(X) by the gen-
eralized sieves functions
log piδ(X;η
∗) = η∗>g(X), µa,δ=1(X;β∗a) = ma{β∗>a g(X)} (a = 0, 1), (9)
16
where for a continuous outcome, ma(·) is the identity link function, and for a binary outcome,
ma(·) is the expit (inverse logit) link function with
η∗> = arg min
η
E[piδ(X)− exp{η>g(X)}]2,
β∗>a = arg min
β
E[µa,δ=1(X)−ma{β>g(X)}]2, (a = 0, 1).
We assume that piδ(x) and µa,δ=1(x), (a = 0, 1) are sufficiently smooth, with piδ(x) sδ-times contin-
uously differentiable, and µa,δ=1(x) sµa-times continuously differentiable for any x in the support
of X with a condition of min(sδ, sµ0 , sµ1) > 4p. Under standard regularity conditions specified in
Section S2 in the supplementary materials, the deterministic differences between the true functions
and the sieves approximations are bounded (Newey, 1997)
sup
x∈X
|piδ(x)− exp{η∗>g(x)}| = O
{
K1−sδ/(2p)
}
, (10)
sup
x∈X
|µa,δ=1(x)−ma{β∗>a g(x)}| = O
{
K1−sµa/(2p)
}
, (a = 0, 1).
Thus, the approximation errors can be made sufficiently small by choosing a large K. However,
it is also necessary that K increases slowly with the sample size n to control the variance of the
sieves estimators. Formally, for the sieves estimators to be consistent and achieve Conditions 1
and 2, K should satisfy K = O(nν), where p/(2s− 4p) < ν < 1/4, for s = sδ, sµ0 and sµ1 ; see the
supplementary material.
Therefore, in the presence of data with complex confounding, choosing K becomes important.
In spite of the importance, there has limited study of the selection ofK in sieves estimation. Imbens
et al. (2005) proposed a selection method through minimizing the mean-squared-error (MSE) of the
ATE over a pre-defined candidate set of K, which requires a rather complicated estimation of the
population MSE and is not automatic. To cope with this issue, we propose a new basis (variable)
selection procedure for sieves estimation of piδ(X) and µa,δ=1(X). We note that the number of
basis functions controls the smoothness of sieves estimators. From this viewpoint, we can specify
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a sufficiently large K˜ as an initial number and apply the penalization technique to regularize the
variability of the estimators.
For penalized sieves estimation of piδ(X), the key insight is that the dual problem of calibration
leads to solving a system of estimating equations given by equation (5). Therefore, we adopt the
penalized estimating equation approach (Johnson et al., 2008; Wang et al., 2012) to facilitate basis
selection. We consider solving the penalized estimating equations
U ξ(λ) = U(λ)− qξ(|λ|)sign(λ),
for λ = (λ1, . . . , λK˜)
T, where qξ(|λ|) = {qξ(|λ1|), . . . , qξ(|λK˜ |)}> is some continuous function,
qξ(|λ|)sign(λ) is the element-wise product of qξ(|λ|) and sign(λ). We let qξ(x) = dpξ(x)/dx,
where pξ(x) is some penalization function. In this paper, we specify pξ(x) to be the smoothly
clipped absolute deviation (SCAD) penalty function (Fan and Li, 2001), although the same dis-
cussion applies to different penalty functions, such as adaptive LASSO (Zou, 2006). Accordingly,
for the SCAD penalty, we have
qξ(|λk|) = ξ
{
I(|λk| < ξ) + (bξ − |λk|)+
(b− 1)ξ I(|λk| ≥ ξ)
}
, k = 1, . . . , K˜,
and we specify b = 3.7 following the suggestion of the literature. Implicitly, we turn the problem of
choosing the number of basis functions K to the problem of choosing the tuning parameter ξ. The
tuning parameter ξ controls the magnitude of the regularization. To help understand the penalized
estimating equation, we discuss two scenarios. If |λk| is large, then qξ(|λk|) is zero, and the kth
component of the estimating equation Uk(λ) is not penalized. Whereas, if |λk| is small but not
zero, then qξ(|λk|) is nonzero and Uk(λ) is penalized. Consequently, the penalty term forces λ̂k
to be zero and excludes the kth element in g(X) from the final selected set of variables. In the
simulation studies, we use 5-fold cross validation to select tuning parameter ξ. The loss function
is specified to be l(λ) =
∑n
i=1 q(Xi;λ) ‖ g(Xi) − g˜ ‖2 /K̂, which quantifies the average degree of
covariate balancing with calibration weights q(Xi;λ), i = 1, . . . , n.
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For penalized sieves estimation of µa,δ=1(X), we can apply the standard penalization technique
for regression models with the pre-specified basis functions based on the trial sample. Specifically,
let
β̂a = arg min
β∈RK˜
 N∑
i=1
δiI(Ai = a)
[
Yi −ma{β>a g(X)}
]2
+
K˜∑
j=1
pξa(|βj|)
 , (11)
where pξa(·) is the SCAD penalty function, for a = 0, 1.
Under standard regularity conditions specified in the supplementary material, the estimator
that solves the penalized estimating equation with the SCAD penalty would possess the oracle
property (see Wang et al., 2012 for details). Therefore, with η̂ = −λ̂, we can obtain ‖η∗ − η̂‖2 =
Op
{
(K/n)1/2
}
. Under certain regularity conditions given in Fan and Li (2001), β̂a satisfies the
selection consistency and oracle properties under penalized likelihood for both linear regression
or logistic regression, and we can obtain ‖β∗a − β̂a‖2 = Op
{
(K/n)1/2
}
, for a = 0, 1. Then, the
penalized sieves estimators of piδ(X) and µa,δ=1(X) satisfy the two conditions in Theorem 4.
Therefore, τˆACW with flexible approximation of the two nuisance functions achieves the usual
root-n consistency and the semiparametric efficiency bound.
4.3 A special case when Y and A are available in the RWE sample
We have utilized the design weighted covariate distribution of the RWE sample to adjust for
selection bias of the RCT sample. Now we consider the setting where we have access to additional
treatment and outcome information (Y,A) from the RWE sample.
Most causal inference methods assumed no unmeasured confounding in the RWE sample, see,
e.g. Lu et al. (2019), that conditioned on X, treatment assignments are independent of potential
outcomes. In practice, however, it may be unlikely that we observe all confounders in the RWE
study. To leverage the predictive power of the RWE sample, we assume the transportability of the
CATE function from the RCT sample to the RWE sample, as formulated below.
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Assumption 7 For a = 0, 1, E(Y | X,A = a, δ˜ = 1) = µa,δ=1(X), abbreviated as µa(X).
Assumption 7 is plausible if X includes a rich set of covariates that influence the outcome.
Unlike the no unmeasured confounding assumption, the transportability assumption is testable
because it is based only on the observed data. For example, one can use the equality test for
nonparametric multivariate regressions of Lavergne (2001).
Under Assumptions 1 - 4 and 7, we have
φ(X,A, Y, δ, δ˜) =
δ
piδ(X)
[
A {Y − µ1(X)}
piA
− (1− A) {Y − µ0(X)}
1− piA
]
+ δ˜d {τ(X)− τ0} .
Therefore, for the ACW estimator τˆACW in (7), the nuisance functions µa,δ=1(X) (a = 01,) can
be estimated based on the RWE sample. This is particularly useful when we adopt the penalized
sieves method. In this case, we approximate µa(X) by the generalized sieves function
µa(X;β
∗
a) = ma{β∗>a g(X)} (a = 0, 1), (12)
and estimate β∗a by
β̂a = arg min
β∈RK˜

N∑
i=1
(δ˜i + δi)I(Ai = a)
[
Yi −ma{β>a g(X)}
]2
+
K˜∑
j=1
pξa(|βj|)
 . (13)
5 Simulation
In this section, we evaluate the finite sample performances of the CW and ACW estimators via
a set of simulation experiments. We first generate a target population of size N = 50000 × 2.
Covariate X ∈ R4 is generated from Xj ∼ N (1, 1) for each j = 1, . . . , 4. For continuous outcomes,
the potential outcome model is
Y (a)|X = −100 + 27.4aX1 + 13.7X2 + 13.7X3 + 13.7X4 + ,
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where  ∼ N (0, 1) for a = 0, 1. Therefore, the true ATE under this setting is τ0 = 27.4E(X1) =
27.4. For binary outcomes, we generate potential outcome according to Y (a)|X ∼ Bernoulli{pa(X)},
where
logit{pa(X)} = 1− 2aX1 −X2 −X3 +X4, (14)
under which the average causal risk difference is τ0 = −0.24. For the first 50000 individuals in
the finite population, we generate the indicator of selection into the RCT sample according to
δ | X ∼ Bernoulli{piδ(X)}, where logit{piδ(X)} = −2.5− 0.5X1 − 0.3X2 − 0.5X3 − 0.4X4. By this
design, the RCT selection rate is around 2%, which results in a roughly n = 1000 subjects in the
RCT sample. The treatment assignment in the RCT sample is A ∼ Bernoulli(0.5). For the second
50000 individuals in the finite population, we take a random sample of sizem = 5000 to form a RWE
sample. For patients in the RWE sample, treatment assignment is A | X ∼ Bernoulli{eA(X)},
where logit{eA(X)} = −X1 + 0.5X2 − 0.25X3 − 0.1X4. The actual observed outcome Y in both
samples is generated by Y = AY (1) + (1− A)Y (0).
To study the impact of model misspecification, following Kang and Schafer (2007), we define a
nonlinear transformation of X to be
X∗ = (exp (X1/3) , X2/ {1 + exp(X1)}+ 10, X1X3/25 + 0.6, X1 +X4 + 20)> ,
and further scale and centerX∗ such that E(X∗j ) = 1 and V (X∗j ) = 1, for j = 1, . . . , 4. Throughout,
we useX for fitting models. We assumeX∗ to be unobserved, but can be used in the true generative
models, in which cases the fitted models are misspecified. We compare the following four model
specification scenarios:
• Scenario 1 (O:C/S:C): both outcome and sampling score models are correctly specified;
• Scenario 2 (O:C/S:W): the outcome model is correctly specified; the sampling score model is
incorrectly specified by using X∗ in the generative model;
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• Scenario 3 (O:W/S:C): the outcome model is incorrectly specified by using X∗ in the gener-
ative model; the sampling score model is correctly specified;
• Scenario 4 (O:W/S:W): both outcome model and sampling score models are incorrectly spec-
ified by using X∗ in the generative model.
To demonstrate the double robustness of the ACW estimator against parametric model misspec-
ification, we consider the calibration variables g1(X) = (X1, X2, X3,X4)
> in all four scenarios.
Moreover, we consider the ACW estimator using sieves estimation, with an initial large num-
ber of basis functions. Specifically, we extend the basis functions in g1(X) to its second or-
der power series that includes all two-way interaction terms and quadratic terms, i.e. g2(X) =
(X1, . . . , Xp, X1X2, . . . , Xp−1Xp, X21 , . . . , X
2
p )
>. For p = 4, g2(X) contains 14 basis functions.
We compare the following estimators for ATE:
1. Naive: the difference in sample means of the two treatment groups in the RCT sample to
demonstrate the degree of selection bias;
2. IPSW: the inverse probability of sampling weighting estimator defined by (1), where the
sampling weights estimated by logistic regression;
3. CW: the calibration weighting estimator defined by (6) with g(X) = g1(X);
4. ACW: the augmented calibration weighting estimator defined by (7) with g(X) = g1(X) and
the nuisance functions µ1(X) and µ0(X) are estimated based on the RWE sample;
5. ACW(S): the penalized augmented calibration weighting estimator using the method of sieves
with g(X) = g2(X).
We use bootstrap variance estimation for all estimators with B = 50. All simulations are all based
on 1000 Monte Carlo replications.
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Table 1 and Figure 2 summarize the results for continuous outcome; Table 2 and Figure 3
summarize the results for binary outcome. It can be seen that the CW estimator is doubly robust
compared to the IPSW estimator for continuous outcomes. The CW estimator for binary outcomes
demonstrates some bias in Scenario 2. This phenomenon is because Assumption 6 does not hold
under the data generating mechanisms (14). The ACW estimator is shown to be doubly robust and
more efficient than the IPSW estimator and the CW estimator. In Scenario 4, where both outcome
and sampling score models are misspecified, we show that the ACW estimator using the method
of sieves is still unbiased and efficient. Moreover, the empirical coverage rates for the unbiased
ACW estimator are close to the nominal level. As the sample size increases, which we show in the
supplementary materials, they become closer to the nominal level.
6 Real data application
We apply the proposed estimators to evaluate the effect of adjuvant chemotherapy for early-stage
resected non-small cell lung cancer (NSCLC). Adjuvant chemotherapy for resected NSCLC is shown
to be effective in stages II and IIIA disease on the basis of RCTs (Massarelli et al., 2003); however,
its utility in the early-stage disease remains unclear. Cancer and Leukemia Group B (CALGB)
9633 is the only trial designed specifically for stage IB NSCLC (Strauss et al., 2008). Nonetheless,
it consists of only 319 patients, which is undersized to detect clinically meaningful improvements.
National Cancer Database (NCDB), as another data source, is a large clinical oncology database
that contains information of more than 70% of the newly diagnosed cancer patients in the US with
more than 34 million historical records.
The comparable sample from the NCDB includes 15207 patients diagnosed with NSCLC be-
tween years 2004 – 2016 with stage IB disease who first had surgery and then received either
adjuvant chemotherapy or on observation (i.e. no chemotherapy) and with age greater than 20;
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Table 1: Simulation results for continuous outcome: bias of point estimates, Monte Carlo variance,
relative bias of bootstrap variance estimate, and the coverage rate of 95% Wald confidence interval.
Naive IPSW CW ACW ACW(S)
Bias
1. O:C/S:C −13.03 −0.00 0.15 0.16 0.15
2. O:C/S:W −11.45 −0.93 0.10 0.12 0.12
3. O:W/S:C −10.99 −0.08 0.19 0.18 0.21
4. O:W/S:W −10.30 −1.92 −1.53 −1.55 −0.00
Monte Carlo variance
1. O:C/S:C 3.45 9.41 1.81 0.15 0.15
2. O:C/S:W 2.94 5.89 1.54 0.15 0.15
3. O:W/S:C 3.34 14.25 6.07 4.78 0.72
4. O:W/S:W 3.00 5.94 1.69 0.98 0.31
Relative bias (%) of bootstrap variance estimate
1. O:C/S:C 3.7 0.2 −2.6 −0.1 1.4
2. O:C/S:W −4.2 3.8 −0.3 −2.3 3.2
3. O:W/S:C 6.9 4.1 −3.0 −5.6 −0.3
4. O:W/S:W 1.0 2.4 −8.2 −5.9 −10.6
95% Wald CI coverage rate
1. O:C/S:C 0.0 93.9 94.1 94.1 93.6
2. O:C/S:W 0.0 93.4 95.6 94.3 95.7
3. O:W/S:C 0.0 94.7 94.3 94.3 92.8
4. O:W/S:W 0.0 85.3 80.1 59.5 92.1
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Figure 2: Boxplot of estimators for continuous outcome under four model specification scenarios.
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Table 2: Simulation results for binary outcome: bias of point estimates, Monte Carlo variance,
relative bias of bootstrap variance estimate, and the coverage rate of 95% Wald confidence interval.
Naive IPSW CW ACW ACW(S)
Bias ×1000
1. O:C/S:C 91.6 0.4 −1.4 −1.9 −1.7
2. O:C/S:W 83.4 −7.1 −17.1 −1.5 −2.0
3. O:W/S:C 77.0 0.1 −1.4 −2.1 −2.0
4. O:W/S:W 72.7 -25.1 −29.8 −19.8 −4.4
Monte Carlo variance ×1000
1. O:C/S:C 0.92 1.51 1.42 0.92 0.97
2. O:C/S:W 0.81 1.19 1.23 0.85 1.02
3. O:W/S:C 0.90 1.56 1.86 1.25 1.24
4. O:W/S:W 0.90 1.31 1.78 1.19 1.21
Relative bias (%) of bootstrap variance estimate
1. O:C/S:C 2.6 −1.7 6.9 1.1 2.4
2. O:C/S:W 12.0 10.9 5.4 0.7 −2.6
3. O:W/S:C −0.6 0.1 −0.2 1.5 −0.2
4. O:W/S:W −2.4 3.8 −1.6 −1.5 2.4
95% Wald CI coverage rate
1. O:C/S:C 15.4 94.0 95.1 94.5 94.6
2. O:C/S:W 20.6 94.5 92.6 94.6 93.1
3. O:W/S:C 26.6 93.8 93.8 94.8 94.5
4. O:W/S:W 31.7 89.6 87.3 89.3 95.3
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Figure 3: Boxplot of estimators for binary outcome under four model specification scenarios.
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Table 3: Number of patients by treatment of the CALGB 9633 trial sample and the NCDB sample.
Observation (A = 0) Adjuvant chemotherapy(A = 1) Total
RCT: CALGB 9633 163 156 319
RWE: NCDB 10936 4271 15207
these patients also did not receive any of the neoadjuvant chemotherapy, radiation therapy, in-
duction therapy, immunotherapy, hormone therapy, transplant/endocrine procedures, or systemic
treatment before their surgery. Thus, the patients in both samples are stage IB NSCLC patients
who either received adjuvant chemotherapy or were on observation after their surgery without any
other interventions.
In our analysis, the treatment indicator A is coded as 1 for adjuvant chemotherapy and 0 for
on observation. A summary of the sample sizes in both samples by treatment groups is given in
Table 3. We include four covariates in the analysis: X1 is gender (1 = male, 0 = female); X2 is
age; X3 is the indicator for histology (1 = squamous, 0 = non-squamous); X4 is the tumor size in
cm. The outcome is the indicator of cancer recurrence within 3 years after the surgery, i.e. Y = 1
if recurrence occurred and Y = 0 otherwise. Table 4 reports the covariate and outcome means of
the two samples. It can be seen that the patients in the CALGB 9633 trial are healthier compared
to the population represented by the NCDB sample, i.e. the trial patients are younger and have
smaller tumor sizes.
We compare the same six methods as in the simulation studies with the same set of basis func-
tions. Bootstrap variance estimation is applied to estimate the standard errors. In the estimation
we standardize age by its mean 67.7 and standard deviation 10.2, and tumor size by its mean 4.9
and standard deviation 3.0. Table 5 reports the results.
The results indicate that in the RCT sample there is a 8.3% decrease in the risk of recurrence
for adjuvant chemotherapy over observation. The IPSW, CW, and ACW estimators, which utilized
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Table 4: Covariate and outcome means comparison of the CALGB 9633 trial sample and the NCDB
sample.
Gender (X1) Age (X2) Histology(X3) Tumor size(X4) Recurrence (Y )
RCT: CALGB 9633 0.64 60.83 0.40 4.60 0.25
RWE: NCDB 0.55 67.87 0.39 4.94 0.33
RWE sample information, show a 9%−11% decrease in the risk of recurrence. However, the causal
effect is not significant according to the 95% confidence interval. The ACW estimator with the
method of sieves gives an estimate of 17% risk decrease; the risk difference is significant at 0.05
level. The difference between the nonparametric ACW estimator and other adjusted estimators
is because the former has second order polynomials selected and used for both calibration and
outcome regression, which also indicates that the sampling score and outcome mean functions used
in IPSW, CW, and ACW estimators are likely to be misspecified. The bootstrap variance estimates
are not distinctive from one another, which is consistent with our simulation results that there is
no clear improvement in efficiency for binary outcomes. All of the RWE-adjusted estimators have
deeper decline in recurrence risk compared to the trial-based Naive estimator, which suggests that
the causal risk difference in the target population is larger than the one of the RCT sample, i.e.
the effect of adjuvant chemotherapy is more profound in the real world population.
7 Concluding remarks
In this paper, we have developed a new semiparametric framework to evaluate the average treatment
effects integrating the complementary features of the RCT and RWE studies under assumptions of
RCT randomization of treatment, transportability of the CATE or the outcome mean functions,
and positivity. As discussed previously, Assumptions 2 and 7 hold if all variables that are related to
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Table 5: Point estimate, standard error and 95% Wald confidence interval of the causal risk differ-
ence between adjuvant chemotherapy and observation based on the CALGB 9633 trial sample and
the NCDB sample.
Est. S.E 95% Wald confidence interval
Naive −0.083 0.048 (−0.177, 0.011)
IPSW −0.088 0.060 (−0.205, 0.029)
CW −0.107 0.062 (−0.227, 0.014)
ACW −0.110 0.065 (−0.236, 0.017)
ACW(S) −0.172 0.082 (−0.333,−0.011)
treatment effect modification and treatment-outcome response are measured. Although essential,
Assumption 2 (ii) is not verifiable based on the observed data but relies on subject matter experts
to assess its plausibility. The transportability of the outcome mean function from the RCT sample
to the RWE sample in Assumption 7 is testable, so potential tests for this assumption can be
developed to verify this assumption. Assumption 3 states that all real-world patients have nonzero
probabilities of participating the RCT. This assumption requires the absence of patient character-
istics that prohibit participation to the RCT. This assumption holds for the CALGB 9633 trial by
its protocol. When the positivity assumption is violated, there is limited overlap in the support of
covariate in RCT and RWE samples, the generalization can only be made to a restricted popula-
tion without extrapolation (Yang and Ding, 2018a). In practice, health scientists should carefully
examine the question at hand to eliminate deterministic violations of positivity.
We assumed that the RCT sample and the RWE sample are independent based on the study
designs for the CALGB trial and the NCDB study. In general, this assumption would be violated
if there are significant overlapping of the two data sources, i.e., they involve a same subset of
patients. We note that the violation of this assumption would not affect the unbiasedness of the
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estimators but variance estimation. Recently, Saegusa (2019) developed a new weighted empirical
process theory for merged data from potential overlapping sources. This inference framework does
not require identifying duplicated individuals and therefore is attractive. In the future, we will
extend this inference framework to our general setting of combining RCT trials and RWE studies.
We have focused on the setting when all relevant covariates in X are captured in both RCT and
RWE studies. However, because RWE studies were not initially collected for research purposes,
some important covariates may not be available from the RWE study. Yang and Ding (2018b)
developed integrative causal analyses of the ATEs combining big main data with unmeasured
confounders and smaller validation data with a full set of confounders; however, they assumed
that the validation sample (i.e. the RCT sample in our context) is representative of the target
population. In the presence of unmeasured covariates in the RWE studies, there may be lingering
selection bias after calibration on the measured covariates. The future work will investigate the
sensitivity to the unmeasured covariates using the methods in Yang and Lok (2017).
There are several other directions for future work: (i) we will extend this framework to the
setting with survival outcomes. Additional challenges arises due to possible right censoring. We
will follow the technique in Bai et al. (2013) to establish the corresponding semiparametric efficiency
theory and estimators in the context of data integration; (ii) RCTs are often underpowered for the
heterogeneity of treatment effect (HTE); on the other hand, RWE studies provide rich information
on individual treatment responses (see Wu et al., 2018; Zhao et al., 2019 for such developments in
precision medicine). We will develop a semiparametric framework for integrative analyses of the
HTE utilizing randomization in the RCT and power of treatment response prediction in the RWE
study.
31
References
Bai, X., A. A. Tsiatis, and S. M. O’Brien (2013). Doubly-robust estimators of treatment-specific
survival distributions in observational studies with stratified sampling. Biometrics 69, 830–839.
7
Bickel, P. J., C. A. Klaassen, P. J. Bickel, Y. Ritov, J. Klaassen, J. A. Wellner, and Y. Ritov
(1993). Efficient and Adaptive Inference in Semiparametric Models. Johns Hopkins University
Press Baltimore. S1.2
Boos, D. D. and L. A. Stefanski (2013). Essential Statistical Inference: Theory and Methods,
Volume 120. Springer Science & Business Media. S1.1
Buchanan, A. L., M. G. Hudgens, S. R. Cole, K. R. Mollan, P. E. Sax, E. S. Daar, A. A. Adimora,
J. J. Eron, and M. J. Mugavero (2018). Generalizing evidence from randomized trials using in-
verse probability of sampling weights. Journal of the Royal Statistical Society: Series A (Statistics
in Society) 181, 1193–1209. 1, 2.2
Chan, K. C. G., S. C. P. Yam, and Z. Zhang (2015). Globally efficient non-parametric inference
of average treatment effects by empirical balancing calibration weighting. Journal of the Royal
Statistical Society: Series B (Statistical Methodology) 78, 673–700. 1
Chang, T. and P. S. Kott (2008). Using calibration weighting to adjust for nonresponse under a
plausible model. Biometrika 95, 555–571. 1
Chen, J., R. Sitter, and C. Wu (2002). Using empirical likelihood methods to obtain range restricted
weights in regression estimators for surveys. Biometrika 89, 230–237. 1
Chen, X. (2007). Large sample sieve estimation of semi-nonparametric models. Handbook of
Econometrics 6, 5549–5632. 1, 4.2
32
Cole, S. R. and E. A. Stuart (2010). Generalizing evidence from randomized clinical trials to target
populations: The actg 320 trial. American Journal of Epidemiology 172, 107–115. 1
Dahabreh, I. J. and M. A. Hernán (2019). Extending inferences from a randomized trial to a target
population. European Journal of Epidemiology 34, 719–722. 1, 2.2
Dahabreh, I. J., S. E. Robertson, and M. A. Hernán (2019). On the relation between g-formula and
inverse probability weighting estimators for generalizing trial results. Epidemiology 30, 807–812.
1
Dahabreh, I. J., S. E. Robertson, E. J. Tchetgen, E. A. Stuart, and M. A. Hernán (2019). Gen-
eralizing causal inferences from individuals in randomized trials to all trial-eligible individuals.
Biometrics 75, 685–694. 1
Dahabreh, I. J., S. E. Robertson, E. J. T. Tchetgen, E. A. Stuart, and M. A. Hernán (2018). Gen-
eralizing causal inferences from individuals in randomized trials to all trial-eligible individuals.
Biometrics 0. 1, 2.2
Fan, J., K. Imai, H. Liu, Y. Ning, and X. Yang (2016). Improving covariate balancing propensity
score: A doubly robust and efficient approach. Technical report, Technical report, Princeton
University. 1
Fan, J. and R. Li (2001). Variable selection via nonconcave penalized likelihood and its oracle
properties. Journal of the American Statistical Association 96, 1348–1360. 4.2, 4.2
Geman, S. and C.-R. Hwang (1982). Nonparametric maximum likelihood estimation by the method
of sieves. The Annals of Statistics 10, 401–414. 4.2
Graham, B. S., C. C. de Xavier Pinto, and D. Egel (2012). Inverse probability tilting for moment
condition models with missing data. The Review of Economic Studies 79, 1053–1079. 1
33
Hahn, J. (1998). On the role of the propensity score in efficient semiparametric estimation of
average treatment effects. Econometrica 66, 315–331. S1.2
Hahn, O. M. and R. L. Schilsky (2012). Randomized controlled trials and comparative effectiveness
research. Journal of Clinical Oncology 30, 4194–4201. 1
Hainmueller, J. (2012). Entropy balancing for causal effects: A multivariate reweighting method
to produce balanced samples in observational studies. Political Analysis 20, 25–46. 1, 3
Hernan, M. A. and T. J. VanderWeele (2011). Compound treatments and transportability of causal
inference. Epidemiology 22, 368. 1
Hershman, D. L. and J. D. Wright (2012). Comparative effectiveness research in oncology method-
ology: observational data. Journal of Clinical Oncology 30, 4215–4222. 1
Hirano, K., G. W. Imbens, and G. Ridder (2003). Efficient estimation of average treatment effects
using the estimated propensity score. Econometrica 71, 1161–1189. S2
Imai, K. and M. Ratkovic (2014). Covariate balancing propensity score. Journal of the Royal
Statistical Society: Series B (Statistical Methodology) 76, 243–263. 1
Imbens, G. W., W. K. Newey, and G. Ridder (2005). Mean-square-error calculations for average
treatment effects. Department of Economics, UC Berkeley, unpublished manuscript . 4.2
Johnson, B. A., D. Lin, and D. Zeng (2008). Penalized estimating functions and variable selection in
semiparametric regression models. Journal of the American Statistical Association 103, 672–680.
4.2
Kang, J. D. Y. and J. L. Schafer (2007, 11). Demystifying double robustness: A comparison
of alternative strategies for estimating a population mean from incomplete data. Statistical
Science 22, 523–539. 5
34
Keiding, N. and T. A. Louis (2016). Perils and potentials of self-selected entry to epidemiological
studies and surveys. Journal of the Royal Statistical Society: Series A (Statistics in Society) 179,
319–376. 1
Kennedy, E. H. (2016). Semiparametric theory and empirical processes in causal inference. In
Statistical Causal Inferences and Their Applications in Public Health Research, pp. 141–167.
Springer. S1.4
Kim, J. K., Y. Kwon, and M. C. Paik (2016). Calibrated propensity score method for survey
nonresponse in cluster sampling. Biometrika 103, 461–473. 1
Korn, E. L. and B. Freidlin (2012). Methodology for comparative effectiveness research: Potential
and limitations. Journal of Clinical Oncology 30, 4185–4187. 1
Kott, P. S. (2006). Using calibration weighting to adjust for nonresponse and coverage errors.
Survey Methodology 32, 133–142. 1
Lavergne, P. (2001). An equality test across nonparametric regressions. Journal of Economet-
rics 103, 307–344. 4.3
Lu, Y., D. O. Scharfstein, M. M. Brooks, K. Quach, and E. H. Kennedy (2019). Causal inference
for comprehensive cohort studies. arXiv preprint arXiv:1910.03531 . 4.3
Massarelli, E., F. Andre, D. Liu, J. Lee, M. Wolf, A. Fandi, J. Ochs, T. Le Chevalier, F. Fossella,
and R. Herbst (2003). A retrospective analysis of the outcome of patients who have received two
prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung
cancer. Lung Cancer 39, 55–61. 6
Newey, W. K. (1997). Convergence rates and asymptotic normality for series estimators. Journal
of Econometrics 79, 147–168. 4.2
35
Neyman, J. (1923). Sur les applications de la thar des probabilities aux experiences Agaricales:
Essay de principle. English translation of excerpts by Dabrowska, D. and Speed, T. Statistical
Science 5, 465–472. 2.1
O’Muircheartaigh, C. and L. V. Hedges (2014). Generalizing from unrepresentative experiments: a
stratified propensity score approach. Journal of the Royal Statistical Society: Series C (Applied
Statistics) 63, 195–210. 1
Pearl, J. and E. Bareinboim (2011). Transportability of causal and statistical relations: A formal
approach. In Data Mining Workshops (ICDMW), 2011 IEEE 11th International Conference on,
pp. 540–547. IEEE. 1
Qin, J. and B. Zhang (2007). Empirical-likelihood-based inference in missing response problems
and its application in observational studies. Journal of the Royal Statistical Society: Series B
(Statistical Methodology) 69, 101–122. 1
Rosenbaum, P. R. and D. B. Rubin (1983). The central role of the propensity score in observational
studies for causal effects. Biometrika 70, 41–55. 1
Rothwell, P. M. (2005). External validity of randomised controlled trials: “to whom do the results
of this trial apply?”. The Lancet 365, 82–93. 1
Rubin, D. B. (1974). Estimating causal effects of treatments in randomized and nonrandomized
studies. Journal of Educational Psychology 66, 688–701. 2.1
Rubin, D. B. (1980). Comment on "Randomization analysis of experimental data: The Fisher
randomization test" by D. Basu. Journal of the American Statistical Association 75, 591–593.
2.1
36
Rudolph, K. E. and M. J. van der Laan (2017). Robust estimation of encouragement design
intervention effects transported across sites. Journal of the Royal Statistical Society: Series B
(Statistical Methodology) 79, 1509–1525. 1, 4.1
Saegusa, T. (2019). Large sample theory for merged data from multiple sources. The Annals of
Statistics 47, 1585–1615. 7
Shen, X. (1997). On methods of sieves and penalization. The Annals of Statistics 25, 2555–2591.
1
Strauss, G. M., J. E. Herndon, M. A. M. II, D. W. Johnstone, E. A. Johnson, D. H. Harpole,
H. H. Gillenwater, D. M. Watson, D. J. Sugarbaker, R. L. Schilsky, et al. (2008). Adjuvant
paclitaxel plus carboplatin compared with observation in stage ib non–small-cell lung cancer:
Calgb 9633 with the cancer and leukemia group b, radiation therapy oncology group, and north
central cancer treatment group study groups. Journal of Clinical Oncology 26, 5043. 6
Stuart, E. A., C. P. Bradshaw, and P. J. Leaf (2015). Assessing the generalizability of randomized
trial results to target populations. Prevention Science 16, 475–485. 1
Stuart, E. A., S. R. Cole, C. P. Bradshaw, and P. J. Leaf (2011). The use of propensity scores
to assess the generalizability of results from randomized trials. Journal of the Royal Statistical
Society: Series A (Statistics in Society) 174, 369–386. 1, 2.2
Sugiyama, M. and M. Kawanabe (2012). Machine Learning in Non-stationary Environments:
Introduction to Covariate Shift Adaptation. MIT press. 1
Tipton, E. (2013). Improving generalizations from experiments using propensity score subclassifica-
tion: Assumptions, properties, and contexts. Journal of Educational and Behavioral Statistics 38,
239–266. 1
37
van der Vaart, A. W. and J. A. Wellner (1996). Weak Convergence and Emprical Processes: With
Applications to Statistics. New York: Springer. S1.4
Wang, L., J. Zhou, and A. Qu (2012). Penalized generalized estimating equations for high-
dimensional longitudinal data analysis. Biometrics 68, 353–360. 4.2, 4.2
Wu, C. and R. R. Sitter (2001). A model-calibration approach to using complete auxiliary infor-
mation from survey data. Journal of the American Statistical Association 96, 185–193. 1
Wu, P., D. Zeng, and Y. Wang (2018). Matched learning for optimizing individualized treatment
strategies using electronic health records. Journal of the American Statistical Association (just-
accepted), 1–35. 7
Yang, S. and P. Ding (2018a). Asymptotic inference of causal effects with observational studies
trimmed by the estimated propensity scores. Biometrika (doi:10.1093/biomet/asy008). 7
Yang, S. and P. Ding (2018b). Combining multiple observational data sources to estimate causal
effects. arXiv preprint arXiv:1801.00802 . 7
Yang, S. and J. J. Lok (2017). Sensitivity analysis for unmeasured confounding in coarse structural
nested mean models. Statist. Sinica (DOI:10.5705/ss.202016.0133). 7
Zhao, Q. and D. Percival (2017). Entropy balancing is doubly robust. Journal of Causal Inference 5,
DOI: https://doi.org/10.1515/jci–2016–0010. 1
Zhao, Y.-Q., D. Zeng, C. M. Tangen, and M. L. Leblanc (2019). Robustifying trial-derived optimal
treatment rules for a target population. Electronic Journal of Statistics 13, 1717–1743. 7
Zou, H. (2006). The adaptive lasso and its oracle properties. Journal of the American Statistical
Association 101, 1418–1429. 4.2
38
Supplementary Materials for “Integrative analysis of random-
ized clinical trials with real world evidence studies”
S1 Proofs
S1.1 Proof of Theorem 1
Proof of the double robustness of the calibration weighting estimator
Let µg0 = E {g(X)}, g¯0 = g(X)−µg0. To use the M-estimator theory (Boos and Stefanski, 2013),
we write (5) as the following estimating equations
1
N
N∑
i=1
C(Xi, δ˜i;µg) =
1
N
N∑
i=1
δ˜idi{g(Xi)− µg} = 0, (S1)
1
N
N∑
i=1
ζ(Xi, δi;λ,µg) =
1
N
N∑
i=1
δi exp
{
λ>g(Xi)
} {g(Xi)− µg} = 0. (S2)
First consider the case where Assumption 5 holds, we have piδ(X) = exp{η>0 g(X)}. Notice that
µg0 is the solution to E{C(X;µg)} = 0. Taking expectation on the left hand side of (S2) with
µg = µg0 leads to
E{ζ(X, δ;λ,µg0)} = E{E(ζ(X, δ;λ,µg0)|X)} = E
(
piδ(X) exp{λ>g(X)} [g(X)− E{g(X)}]
)
.
For the above conditional expectation to be zero, one needs piδ(X) exp{λ>g(X)} to be a constant.
As piδ(X) = exp{ηT0g(X)}, we have piδ(X) exp{λ>g(X)} = exp{(η0 + λ)>g(X)}. Thus λ = −η0
makes (S2) a system of unbiased estimating equations. We point out that denominator in q̂i is an
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estimator of the population size N , i.e.
1
N
n∑
i=1
exp{λ>g(Xi)} = 1
N
N∑
i=1
δi exp{λ>g(Xi)}
=
1
N
N∑
i=1
δi exp
{−η>0 g(Xi)}+Op(n−1/2N−1)
= 1 +Op(N
−1/2) +Op(n−1/2N−1)
= 1 + op(1).
Therefore,
q̂i = q(Xi; λ̂) =
exp
{
λ̂>g(Xi)
}
∑n
i=1 exp
{
λ̂>g(Xi)
} = 1
N
1
piδ(Xi;η0)
+Op(n
−1/2N−1); (S3)
i.e. q̂i {Npiδ(Xi;η0)} → 1 as n→∞. Based on (S3), we have
τˆCW =
N∑
i=1
q̂iδi
{
AiYi
piAi
− (1− Ai)Yi
1− piAi
}
(S4)
=
1
N
N∑
i=1
δi
piδ(Xi;η0)
{
AiYi
piAi
− (1− Ai)Yi
1− piAi
}
= τ0 +Op(N
−1/2) +Op(n−1/2)
= τ0 + op(1).
Therefore, τˆCW is consistent for τ0.
Now consider the case where Assumption 6 holds. Then we have
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E(
n∑
i=1
q̂i
{
AiYi
piAi
− (1− Ai)Yi
1− piAi
})
= E
[
n∑
i=1
q̂iE
{
AiYi
piAi
− (1− Ai)Yi
1− piAi | Xi, δi = 1
}]
= E
[
n∑
i=1
q̂iE {Y (1)− Y (0) | Xi, δi = 1}
]
= γ>0 E
{
n∑
i=1
q̂ig(Xi)
}
= γ>0 E
{
1
N
N∑
i=1
δ˜idig(Xi)
}
= E
{
γ>0 g(X)
}
= τ0,
where the equation on the third line is obtained by the balancing constraint (2). Under mild
regularity conditions for unbiased M-estimators, τˆCW is consistent for τ0.
We thus conclude the double robustness of τˆCW.
Proof of the asymptotic variance for the calibration weighting estimator
We derive the asymptotic variance of τˆCW under Assumption (5) and (6) to facilitate the efficiency
comparison of τˆCW and τˆACW.
Let θ = (µ>g ,λ>, piA, τ)> to denote the vector of all parameters. The estimating function for θ
is
ψ(X,A, Y, δ, δ˜;θ) =

C(X, δ˜;µg)
ζ(X, δ;λ,µg)
h(X,A, δ;λ, piA)
t(X,A, Y, δ;λ, piA, τ)
 ,
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where C(X, δ˜;µg) and ζ(X, δ;λ,µg) are given in (S1), (S2), respectively, and
h(X,A, δ;λ, piA) = δ exp{λ>g(X)}(A− piA),
t(A,X, Y, δ;λ, piA, τ) = δ exp{λ>g(X)}
{
AY
piA
− (1− A)Y
1− piA − τ
}
.
Then θ̂ = (µ̂>g , λ̂>, pˆiA, τˆCW1)> solves the joint estimating equation
1
N
N∑
i=1
ψ(Xi, Ai, Yi, δi;θ) = 0.
Under standard regularity conditions in the M-estimator theory, we have
θ̂ − θ0 = 1
N
N∑
i=1
ψ(Xi, Ai, Yi, δi;θ0) + op(N
−1/2),
where A(θ0) = E {−∇θ0ψ(θ0)}, and θ0 = (µ>g0,−η>0 , piA, τ0)>. The asymptotic variance of
N−1/2(θ̂ − θ0) is A−1(θ0)B(θ0)A−1(θ0)>, where B(θ0) = E
{
ψ(θ0)ψ(θ0)
>}.
To further express the asymptotic variance, we denote q0 = q0(X) = exp{−η0>g(X)} and
τ¯(Y,A) = {AY/piA − (1− A)Y/(1− piA)− τ0}. Note that E{τ¯(Y,A)|X, δ = 1} = τ(X) − τ0 and
E
(
δ˜d
)
= 1. Under Assumption 5 and 6, piδ(X)q0(X)= 1 and τ(X)− τ0 = γ>0 g¯0. In the following
derivation we use ⇒ to indicate equality when both Assumption 5 and 6 hold.
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Using iterated expectation, we have
A(θ0) = E {−∇θ0ψ(θ0)}
= E

δ˜dIK 0K×K 0K×1 0K×1
δq0IK −δq0g¯g> 0K×1 0K×1
01×K −δq0(A− piA)g> δq0 0
01×K −δq0τ¯(Y,A)g> δq0
{
AY
pi2A
+ (1−A)Y
(1−piA)2
}
δq0

=

IK 0K×K 0K×1 0K×1
E (δq0) IK −E{δq0(g − µg0)g>} 0K×1 0K×1
01×K 01×K E (δq0) 0
01×K −E
[
piδ(X)q0 {τ(X)− τ0} g>
]
E
[
δq0
{
AY
pi2A
+ (1−A)Y
(1−piA)2
}]
E (δq0)
 .
By block matrix inversion,
A(θ0)
−1 =

IK 0K×K 0K×1 0K×1
E
(
δq0g¯0g
>) −1E(δq0) −E (δq0g¯0g>) −1 0K×1 0K×1
01×K 01×K E(δq0)−1 0
A41 A42 A43 A44
 ,
where
A41 = E
[
δq0(X) {τ(X)− τ0} g>
]
E
{
δq0(X)g¯0g
>} −1 ⇒ γ>0 IK ,
A42 = −E {δq0(X)} −1E
[
piδ(X)q0(X) {τ(X)− τ0} g>
]
E
{
δq0(X)g¯0g
>}−1 ⇒ −γ>0 IK ,
A43 = −E {δq0(X)}−2E
[
δq0(X)
{
AY
pi2A
+
(1− A)Y
(1− piA)2
}]
⇒ −E
[
δq0(X)
{
Y (1)
piA
+
Y (0)
1− piA
}]
,
A44 = E {δq0(X)} −1 ⇒ 1.
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Taking iterated expectation again, we have
B(θ0) = E
{
ψ(θ0)ψ(θ0)
>}
= E

δ˜d2g¯0g¯
>
0 0K×K 0K×1 0K×1
0K×K δq0(X)2g¯0g¯>0 δq0(X)
2(A− piA)g¯0 δq0(X)2τ¯(Y,A)g¯0
01×K δq0(X)2(A− piA)g¯>0 δq0(X)2(A− piA)2 δq0(X)2τ¯(Y,A)(A− piA)
01×K δq0(X)2τ¯(Y,A)g¯>0 δq0(X)
2τ¯(Y,A)(A− piA) δq0(X)2τ¯(Y,A)2

=

B11 0K×K 0K×1 0K×1
0K×K B22 0K×1 B24
01×K 01×K B33 B34
01×K B>24 B34 B44
 ,
where
B11 = E
(
δ˜d2g¯0g¯
>
0
)
,
B22 = E{δq0(X)2g¯0g¯>0 } ⇒ E{q0(X)g¯0g¯>0 },
B24 = E
[
δq0(X)
2 {τ(X)− τ0} g¯0
]⇒ E {q0(X)γ>0 g¯0g¯0} ,
B33 = E{δq0(X)2V (A|X)} ⇒ piA(1− piA)E {q0(X)} ,
B34 = E{δq20(X)τ¯(Y,A)(A− piA)} = E
[
δq20(X) {(1− piA)Y (1) + piAY (0)}
]
,
B44 = E{δq20(X)τ¯(Y,A)2} = E
[
δq20(X)
{
Y (1)2
piA
+
Y (0)2
1− piA − 2τ(X)τ0 + τ
2
0
}]
.
We can express the asymptotic variance of N−1/2(τˆCW − τ0) as V CW = A41B11A>41 + A244B44.
Under Assumption 5 and 6, we have A41B11A>41 = E
[
δ˜d2 {τ(X)− τ0}2
]
. Therefore, V CW can
be simplified as
V CW = E
[
δ˜d2 {τ(X)− τ0}2
]
+ E
[
δq20(X)
{
Y (1)2
piA
+
Y (0)2
1− piA − 2τ(X)τ0 + τ
2
0
}]
.
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S1.2 Proof of Theorem 2
Let Z = (X,A, Y, δ, δ˜) be a vector of random variables. Assumptions 1 - 3 constitute the semipara-
metric model. The semiparametric likelihood based on a single Z is
f(Z) = {f(X)f(A, Y |X, δ = 1)piδ(X)}δ {f(X)}δ˜ ,
where f(·) is a density function for a continuous random variable and is a probability mass function
for a discrete random variable.
Assuming that δδ˜ = 0, the score function(Hahn, 1998) satisfies
S(X,A, Y, δ, δ˜) = S(X,A, Y, δ) + δ˜S(X).
We first list four identities that are used in the following derivation of the efficiency bound:
I1. For any function h(X,A, δ), we have E{h(X,A, δ)S(Y |X,A, δ)} = 0;
I2. any function h(X,A, δ), we have E[h(X,A, δ){Y − E(Y |X,A, δ)}] = 0;
I3. any h(X,A, Y ), if E
{
δ˜h(X,A, Y )
}
= 0, we have E{δ˜h(X,A, Y )S(X,A, Y, δ)} = 0
I4. any h(X,A, Y ), if E {δh(X,A, Y )} = 0, we have E
{
δh(X,A, Y )δ˜S(X)
}
= 0.
To derive the semiparametric efficiency score, we use the method of parametric submodel (Bickel
et al., 1993). Let {ft(Z) : t ∈ R} be a regular parametric submodel which contains the truth at
t = 0, i.e. ft(Z)|t=0 = f(Z).
Note that τ(X) = E(Y |X,A = 1, δ = 1) − E(Y |X,A = 0, δ = 1) and τ0 = E
{
δ˜dτ(X)
}
.
Let τt = Et
{
δ˜dτt(X)
}
denote the parameter τ evaluated with respect to the regular parametric
submodel ft(Z). Following Bickel et al. (1993), the semiparametric efficiency score φ = φ(Z) is the
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pathwise derivative of the target parameter in the sense that
∂
∂t
τt
∣∣∣∣
t=0
= E{φS(Z)},
where S(Z) = ∂logft(Z)/∂t|t=0. Toward this end, we express
∂
∂t
τt
∣∣∣∣
t=0
= E
{
δ˜dτ(X)S(X)
}
+ E
{
∂τt(X)
∂t
∣∣∣∣
t=0
}
. (S5)
For the first term in the right hand side of (S5), we have
E
{
δ˜dτ(X)S(X)
}
= E
[
δ˜d {τ(X)− τ0}S(X)
]
= E
[
δ˜d {τ(X)− τ0}
{
S(X,A, Y, δ) + δ˜S(X)
}]
(S6)
= E
[
δ˜d {τ(X)− τ0}S(X,A, Y, δ, δ˜)
]
,
where(S6) holds because of identity I3. To express further the second term in the right hand side
of (S5), we have
∂τt(X)
∂t
∣∣∣∣
t=0
=
{∫
y
∂
∂t
ft(y|X, δ = 1, A = 1)dy −
∫
y
∂
∂t
ft(y|X, δ = 1, A = 0)dy
}∣∣∣∣
t=0
=
{∫
yS(y|X,A = 1, δ = 1)ft(y|X,A = 1, δ = 1)dy
}∣∣∣∣
t=0
−
{∫
yS(y|X,A = 0, δ = 1)ft(y|X,A = 0, δ = 1)dy
}∣∣∣∣
t=0
= E
{
δAY
piδ(X)piA
S(Y |A,X, δ)|X
}
− E
{
δ(1− A)Y
piδ(X)(1− piA)S(Y |A,X, δ)|X
}
= E
[
δ
piδ(X)
{
AY
piA
− (1− A)Y
(1− piA)
}
S(Y |A,X, δ)|X
]
.
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Therefore,
E
{
∂τt(X)
∂t
∣∣∣∣
t=0
}
= E
[
δ
piδ(X)
{
AY
piA
− (1− A)Y
(1− piA)
}
S(Y |A,X, δ)
]
= E
(
δ
piδ(X)
[
A{Y − µ1,δ(X)}
piA
− (1− A){Y − µ0,δ(X)}
1− piA
]
S(Y |A,X, δ)
)
(S7)
= E
(
δ
piδ(X)
[
A{Y − µ1,δ(X)}
piA
− (1− A){Y − µ0,δ(X)}
1− piA
]
S(X,A, Y, δ)
)
(S8)
= E
(
δ
piδ(X)
[
A{Y − µ1,δ(X)}
piA
− (1− A){Y − µ0,δ(X)}
1− piA
]
S(X,A, Y, δ, δ˜)
)
.
(S9)
In the above derivation, (S7) follows by identity I1, (S8) follows by identity I2, and (S9) follows by
identities I3 and I4.
Substituting back to (S5), we have
∂
∂t
τt
∣∣∣∣
t=0
= E
{(
δ˜d {τ(X)− τ0}+ δ
piδ(X)
[
A{Y − µ1,δ(X)}
piA
− (1− A){Y − µ0,δ(x)}
1− piA
])
S(X,A, Y, δ, δ˜)
}
Thus, the semiparametric efficiency score is
φ = δ˜d {τ(X)− τ0}+ δ
piδ(X)
[
A{Y − µ1,δ(X)}
piA
− (1− A){Y − µ0,δ(X)}
(1− piA)
]
.
It follows that the semiparametric efficiency bound is
E(φ2) = E
[
δ˜d2 {τ(X)− τ0}2 + δ
pi2δ (X)
{
V {Y (1)|X, δ}
piA
+
V {Y (0)|X, δ}
1− piA
}]
.
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S1.3 Proof of Theorem 3
Proof of the double robustness of the ACW estimator
Let θ = (η,β0,β1) denote the vector of nuisance parameters. Note that τˆACW is the solution to
the estimating equation N−1
∑N
i=1 φ(Xi, Ai, Yi, δi, δ˜i; τ, θ̂) = 0, where
φ(X,A, Y, δ, δ˜; τ,θ) =
δ
piδ(X;η)
[
A {Y − µ1,δ(X;β1)}
piA
− (1− A) {Y − µ0,δ(X;β0)}
1− piA
]
+ δ˜d {µ1,δ=1(X;β1)− µ0,δ=1(X;β0)} − τ.
Let θ∗ be the probability limits of θ̂. It suffices to show that E
{
φ(X,A, Y, δ, δ˜; τ0,θ
∗)
}
= 0 if either
pi(X;η) or µa,δ=1(X;βa) (a = 0, 1) is correctly specified. Under standard regularity conditions for
M-estimators, τˆACW is consistent for τ . Use iterated expectation, we can write
E
{
φ(X,A, Y, δ, δ˜; τ0,θ
∗)
}
= E
[
δ
piδ(X;η∗)
{
AY
piA
− (1− A)Y
1− piA
}
− τ0
]
+
E
[{
δ˜d− δ
piδ(X;η∗)
}
{µ1,δ=1(X;β∗1)− µ0,δ=1(X;β∗0)}
]
. (S10)
The first term on the left-hand-side of (S10) is 0 either one of the pi(X;η) or µa,δ=1(X;βa) (a = 0, 1)
is correctly specified, as shown in the proof of consistency in the CW estimators. Now consider the
second term on the left-hand-side of (S10).
Firstly, if piδ(X;η) is correctly specified, we have piδ(X;η∗) = piδ(X). Take iterated expectation
conditional on X, we have the second term on the left-hand-side of (S10)
E
[{
δ˜d− δ
piδ(X)
}
{µ1,δ=1(X;β∗1)− µ0,δ=1(X;β∗0)}
]
= E
[
{µ1,δ=1(X;β∗1)− µ0,δ=1(X;β∗0)}E
{
δ˜d− δ
piδ(X)
|X
}]
= 0,
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as E
{
δ˜d− δ/piδ(X)|X
}
= 0. Thus, (S10) equals to zero.
Secondly, if outcome model µa,δ=1(X;βa) (a = 0, 1) is correctly specified, we have µ1,δ=1(X;β∗1)−
µ0,δ=1(X;β
∗
0) = γ
>
0 g(X). Then the second term on the left-hand-side of (S10) satisfies
E
[{
δ˜d− δ
piδ(X)
}
{µ1,δ=1(X;β∗1)− µ0,δ=1(X;β∗0)}
]
= E
[
γ>0
{
δ˜d− δ/piδ(X;η∗)
}
g(X)
]
= 0
by the balancing constraint (2). Thus, (S10) equals to zero under this scenario as well. This
completes the proof of the double robustness of τˆACW.
S1.4 Proof of Theorem 3 and Theorem 4
Proof of local efficiency
Following the empirical process literature, let PN denote the empirical measure. For a random
variable V , P{f(V )} = ∫ f(v)dP is the expectation of f(V ) under the true data-generating process.
Recall that Z = (X,A, Y, δ, δ˜) , θ = (η,β0,β1), θ∗ is the probability limits of θ̂ and θ0 is the
corresponding true parameter value. Let
ψ(Z;θ) =
δ
piδ(X;η)
[
A {Y − µ1,δ=1(X;β1)}
piA
− (1− A) {Y − µ0,δ=1(X;β0)}
1− piA
]
+δ˜d {µ1,δ=1(X;β1)− µ0,δ=1(X;β0)}
=
δ
piδ(X;η)
A{Y − µ1,δ=1(X;β1)}
piA
+ δ˜dµ1,δ=1(X;β1)
− δ
piδ(X;η)
(1− A){Y − µ0,δ=1(X;β0)}
1− piA − δ˜dµ0,δ=1(X;β0)
=: ψ1(Z;θ)− ψ0(Z;θ).
Under the conditions specified in Theorem 3 or the conditions specified in Theorem 4, and as-
sume that ψ(Z;θ) belongs to Donsker classes (van der Vaart and Wellner, 1996; Kennedy, 2016),
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Pψ1(Z;θ∗) = µ1, Pψ0(Z;θ∗) = µ0 and Pψ(Z;θ∗) = µ1 − µ0 = τ0. Thus,
τˆACW − τ0 = PNψ(Z; θ̂)− Pψ(Z;θ∗)
= (PN − P)ψ(Z; θ̂) + P{ψ(Z; θ̂)− ψ(Z;θ∗)}
= (PN − P)ψ(Z;θ∗) + P{ψ(Z; θ̂)− ψ(Z;θ∗)}+ op(N−1/2). (S11)
We now show that
P{ψ(Z; θ̂)− ψ(Z;θ∗)} = P{ψ1(Z; θ̂)− ψ1(Z;θ∗)} − P{ψ0(Z; θ̂)− ψ0(Z;θ∗)}
is a small order term under conditions in Theorem 3 or Theorem 4. We write
P{ψ1(Z; θ̂)− ψ1(Z;θ∗)} =P
 δ
piδ(X; η̂)
A
{
Y − µ1,δ=1(X; β̂1)
}
piA
+ δ˜dµ1,δ=1(X; β̂1)− µ1

=P
[{
δ
piδ(X; η̂)
− 1
}{
µ1,δ=1(X)− µ1,δ=1(X; β̂1)
}
+
(
δ˜d− 1
)
µ1,δ=1(X; β̂1)
]
=P
[{
piδ(X)− piδ(X; η̂)
piδ(X; η̂)
}{
µ1,δ=1(X)− µ1,δ=1(X; β̂1)
}]
.
Similarly, we have
P{ψ0(Z; θ̂)− ψ0(Z;θ∗)} = P
[{
piδ(X)− piδ(X; η̂)
piδ(X; η̂)
}{
µ0,δ=1(X)− µ0,δ=1(X; β̂0)
}]
.
Therefore, by Cauchy-Schwarz inequality and the positivity of piδ(X; η̂), |P{ψ(Z; θ̂) − ψ(Z;θ∗)}|
is bounded above by
‖piδ(X)− piδ(X; η̂)‖
∑
a∈{0,1}
‖µa,δ=1(X)− µa,δ=1(X; β̂a)‖. (S12)
Under the conditions in Theorem 3, if piδ(X;η) is a correctly specified parametric model for piδ(X),
then ‖piδ(X) − piδ(X; η̂)‖ = Op(n−1/2); and if µa,δ=1(X;βa) is a correctly specified parametric
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model for µa,δ=1(X), then ‖µa,δ=1(X)− µa,δ=1(X; β̂a)‖ = Op(n−1/2). Therefore, the product (S12)
is Op(n−1), which makes P{ψ(Z; θ̂)−ψ(Z;θ∗)} in (S11) asymptotically negligible. Under the con-
ditions in Theorem 4, the product (S12) is op(n−1/2) and therefore the term P{ψ(Z; θ̂)−ψ(Z;θ∗)}
in (S11) is asymptotically negligible. The result follows.
S2 Conditions for the sieves estimator
Following Hirano et al. (2003), we assume the following regularity conditions on the data generating
process and the nuisance functions.
Condition S3 (Distribution of X) Let X ⊆ Rp be the support of X. Assume that X is a
Cartesian product of compact intervals, i.e. X = ∏pj=1 [lj, uj], lj, uj ∈ R. The density of X, f(X),
is bounded above and below away from 0 on X .
Condition S4 (Basis functions) There exist constant l and u such that l ≤ ρmin{g(X)>g(X)} ≤
ρmax{g(X)>g(X)} ≤ u, almost surely where ρmin and ρmax denote the minimum and maximum
eigenvalues of a matrix.
Condition S5 (Potential outcomes) The second moment of the potential outcomes are finite.
i.e. E {Y (a)2} <∞, for a = 0, 1.
Condition S6 (Smoothness) The log sampling score function log piδ(x) is sδ-times continuously
differentiable and the outcome mean function µa(x) is sµa-times continuously differentiable, ∀x ∈
X , a = 0, 1; The sieves estimators of log piδ(x) and µa(x) use a power series; the smoothness
condition is s > 4p, for s = sδ and s = sµa (a = 0, 1), respectively.
and
The constraint s > 4p is required such that ν exists in the following condition for the number
of basis functions.
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Condition S7 (Number of basis function) The number of basis functions K satisfies K =
O(nν), where p/(2s− 4p) < ν < 1/4.
Under the above conditions, the bias of the sieves approximations are Op(K1−s/(2p)) = op(n−1/4).
Moreover, because K4 = o(n), the variances of the sieves approximations are Op(K/n) = op(n−1/2).
To present regularity conditions for the penalization approach to choosing K, we introduce
more notation. Let the support of model parameters be
Mδ = {1 ≤ j ≤ K˜ : η∗j 6= 0}, Ma = {1 ≤ j ≤ K˜ : β∗a,j 6= 0}, (a = 0, 1).
Define Kη = ||η∗||0, Ka = ||β∗a||0 (a = 0, 1), K = max(Kη, K0, K1), and ξmin = min(ξ, ξ0, ξ1). Let
C, C1 and C2 be generic constants. For any J ⊆ {1, . . . , K˜} and any vector η ∈ RK˜ , let ηJ be the
sub-vector of η formed by elements of η whose indexes are in J . Let J c be the complement of J .
Assumption S1 The following regularity conditions hold.
(A1) The parameter (ηT,βT0 ,βT1 )T belongs to a compact subset in R3K˜, and (η∗T,β∗T0 ,β∗T1 )T lies
in the interior of the compact subset.
(A2) Let δ,i(η) = δi − exp{η>g(Xi)}. There exists a constant C such that E{|δ,i(η∗)|2+δ} ≤ C
for all i and some δ > 0. There exist constants C1 and C2 such that E[exp{C1|δ,i(η∗)|} |
Xi] ≤ C2 for all i.
(A3) exp(1){η>g(Xi)}, exp(2){η>g(Xi)}, and exp(3){η>g(Xi)} (which denote the first, second
and third derivative of exp{η>g(Xi)}, respectively) are uniformly bounded away from ∞ on
Nδ,τ = {η ∈ RK˜ : ||ηMδ − η∗Mδ || ≤ τ
√
K/n,ηMcδ = 0} for some τ > 0.
(A4) For a = 0, 1, let a,i(βa) = Yi(a) − ma{β>a g(Xi)}. There exists a constant C such that
E{|a,i(β∗a)|2+δ} ≤ C for all i and some δ > 0. There exist constants C1 and C2 such that
E[exp{C1|a,i(β∗a)|} | Xi] ≤ C2 for all i.
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(A5) For a = 0, 1, m(1)a {β>a g(X)}, m(2)a {β>a g(X)}, and m(3)a {β>a g(X)} (which denote the first,
second and third derivative of ma{β>a g(X)}, respectively) are uniformly bounded away from
∞ on Na,τ = {βa ∈ RK˜ : ||βa,Ma − β∗a,Ma || ≤ τ
√
K/n,βa,Mca = 0} for some τ > 0.
(A6) minj∈Mδ |η∗j |/ξ →∞ and minj∈Ma |β∗a,j|/ξa →∞, (a = 0, 1) as n→∞.
(A7) K = o(n1/3), ξmin → 0, (log n)2 = o(nξ2min), log(K˜) = o {nξ2min/ (log n) 2}, K˜K4(log n)6 =
o(n3ξ2min), K˜K4(log n)8 = o(n4ξ4min), as n→∞.
These assumptions are typical in the penalization literature. Assumptions (A2) and (A4) hold
for Gaussian distribution, sub-Gaussian distribution, and so on. Assumptions (A3) and (A5) hold
for common models. Assumption (A7) specifies the restrictions on the initial number of sieves
functions K˜ and the maximum dimension of the true nonzero coefficients K. To gain insight, when
the true model size K = O(nν), where ν satisfies Condition S7, then K˜ = O(nν˜) with ν˜ < 2− 4ν
meets the (A7) requirement.
S3 Additional simulation study
We conduct additional simulation studies to evaluate the effect of sample sizes on the performance
of our proposed estimators.
S3.1 Increased sample sizes
In this simulation study, we increase the population size to N = 500000, the RWE sample size to
m = 10000, and the RCT selection rate to 0.45% that leads to n = 2250 to study the effect of
sample size. Results are shown in Table 6 for continuous outcome and Table 7. It can be seen that
when the sample sizes are larger, the advantages of our proposed estimators become more obvious.
The coverage rate for both continuous outcome and binary outcome are closer to the nominal rate.
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Naive IPSW CW ACW ACW(S)
Bias
1. O:C/S:C 13.64 −0.09 0.07 0.05 0.05
2. O:C/S:W −11.80 −1.20 0.06 0.06 0.06
3. O:W/S:C −11.39 −0.10 0.03 0.02 0.00
4. O:W/S:W −11.01 −2.68 −1.59 −1.58 0.02
Monte Carlo variance
1. O:C/S:C 1.53 5.23 1.02 0.08 0.08
2. O:C/S:W 1.38 2.98 0.74 0.08 0.08
3. O:W/S:C 1.51 8.87 4.10 3.23 0.09
4. O:W/S:W 1.42 2.98 0.88 0.48 0.10
Relative bias (%) of bootstrap variance estimate
1. O:C/S:C 2.3 0.6 −4.4 −1.2 −0.1
2. O:C/S:W 4.3 1.0 8.2 2.1 2.5
3. O:W/S:C −1.1 −0.3 −11.0 −13.7 1.2
4. O:W/S:W 1.9 0.8 12.6 −2.8 −1.4
95% Wald CI coverage
1. O:C/S:C 0.0 94.0 93.6 94.6 94.6
2. O:C/S:W 0.0 88.0 95.1 93.9 93.8
3. O:W/S:C 0.0 92.3 94.1 91.7 94.9
4. O:W/S:W 0.0 62.3 63.2 33.7 94.9
Table 6: Simulation results for continuous outcome with population size N = 500000: bias of point
estimates, Monte Carlo variance, relative bias of bootstrap variance estimate, and the coverage
rate of 95% Wald confidence interval.
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Naive IPSW CW ACW ACW(S)
Bias ×1000
1. O:C/S:C 94.75 0.49 −1.08 −0.22 −0.28
2. O:C/S:W 87.52 −8.73 −16.20 −1.59 −1.58
3. O:W/S:C 80.35 1.93 0.50 1.23 0.93
4. O:W/S:W 76.53 −24.52 −26.57 −17.82 −2.95
Monte Carlo variance ×1000
1. O:C/S:C 0.40 0.70 0.69 0.43 0.44
2. O:C/S:W 0.38 0.55 0.54 0.36 0.44
3. O:W/S:C 0.38 0.71 0.85 0.61 0.56
4. O:W/S:W 0.38 0.57 0.75 0.50 0.52
Relative bias (%) of bootstrap variance estimate
1. O:C/S:C 1.8 −4.8 −2.5 −3.4 −4.2
2. O:C/S:W 2.7 5.2 4.6 2.8 −4.3
3. O:W/S:C 1.1 −2.8 −5.6 −10.0 −7.3
4. O:W/S:W 1.9 8.3 3.4 2.9 0.9
95% Wald CI coverage
1. O:C/S:C 0.4 94.3 94.5 94.4 93.8
2. O:C/S:W 1.0 94.0 90.1 95.3 94.2
3. O:W/S:C 2.3 94.0 93.6 93.2 93.4
4. O:W/S:W 2.1 82.9 83.2 86.7 95.3
Table 7: Simulation results for binary outcome with population size N = 500000: bias of point
estimates, Monte Carlo variance, relative bias of bootstrap variance estimate, and the coverage
rate of 95% Wald confidence interval.
55
